{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:42:45Z","timestamp":1788892965962,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005300","name":"American Chemical Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM075762"],"award-info":[{"award-number":["T32GM075762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM145773"],"award-info":[{"award-number":["T32GM145773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI136904"],"award-info":[{"award-number":["AI136904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI167284"],"award-info":[{"award-number":["AI167284"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejmech.2023.115329","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:39:30Z","timestamp":1680233970000},"page":"115329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii"],"prefix":"10.1016","volume":"253","author":[{"given":"Santiana A.","family":"Marrujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica B.","family":"Hubble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansley M.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Barlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta J.","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayland","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-4696","authenticated-orcid":false,"given":"Christian","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115329_bib1","series-title":"Antibiotic Resistance Threats in the United States","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115329_bib2","series-title":"WHO. Antimicrobial Resistance: Global Report on Surveillance","year":"2014"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115329_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115329_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115329_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115329_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of acinetobacter infections: a century of challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115329_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10081006","article-title":"Infections in times of COVID-19 pandemic","volume":"10","author":"Rangel","year":"2021","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115329_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","article-title":"The challenge of overcoming antibiotic resistance: an adjuvant approach?","volume":"3","author":"Melander","year":"2017","journal-title":"ACS Infect. Dis."},{"issue":"18","key":"10.1016\/j.ejmech.2023.115329_bib9","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115329_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ejmech.2023.115329_bib11","article-title":"Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants","volume":"80","author":"Melander","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2023.115329_bib12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/acsmedchemlett.0c00276","article-title":"Augmenting the activity of macrolide adjuvants against Acinetobacter baumannii","volume":"11","author":"Hubble","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115329_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/acsinfecdis.9b00067","article-title":"Small molecule potentiation of gram-positive selective antibiotics against","volume":"5","author":"Martin","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115329_bib14","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/JB.00906-15","article-title":"Pathogenic acinetobacter: from the cell surface to infinity and beyond","volume":"198","author":"Weber","year":"2015","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejmech.2023.115329_bib15","series-title":"M100Performance Standards for Antimicrobial Susceptibility Testing","author":"CaLS","year":"2021"},{"issue":"17","key":"10.1016\/j.ejmech.2023.115329_bib16","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1021\/jm501050e","article-title":"Small-molecule suppression of \u03b2-lactam resistance in multidrug-resistant gram-negative pathogens","volume":"57","author":"Brackett","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115329_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.01897-13","article-title":"Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities","volume":"58","author":"Taitt","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115329_bib18","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/JB.06749-11","article-title":"Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis","volume":"194","author":"Zurawski","year":"2012","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115329_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115329_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/adt.2007.103","article-title":"An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion","volume":"6","author":"McNaney","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2023.115329_bib21","first-page":"3","article-title":"Isolation and characterization of lipopolysaccharides","volume":"431","author":"Apicella","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115329_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4049\/jimmunol.165.2.618","article-title":"Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2","volume":"165","author":"Hirschfeld","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115329_bib23","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1124\/dmd.106.010793","article-title":"Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes","volume":"34","author":"Lu","year":"2006","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:52:27Z","timestamp":1778676747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":23,"alternative-id":["S0223523423002957"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115329","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115329"}}